COENZILE 10,000µg/20ml, lyophilised, and solvent for solution for injection for cattle, horses, swine, dogs and cats

Land: Zypern

Sprache: Griechisch

Quelle: Κυπριακή Δημοκρατία, Υπουργείο Γεωργίας, Αγροτικής Ανάπτυξης και Περιβάλλοντος, Κτηνιατρικές Υπηρεσίες

Wirkstoff:

GRANTED

Verfügbar ab:

QB03BA04

ATC-Code:

COBAMAMIDE 10.000 μg/ 20ml

INN (Internationale Bezeichnung):

GRANTED

Darreichungsform:

FATRO SpA ITALY

Verabreichungsweg:

LYOPHILISATE AND SOLVENT FOR SOLUTION FOR INJECTION

Therapiegruppe:

N. A. CHANCE TRADING CO

Produktbesonderheiten:

Withdrawal period: CATTLE HORSES PIGS DOGS CATS; Distributor: ANTIANEMIC PREPARATIONS

Fachinformation

ΠΑΡΑΡΤΗΜΑ Ι
ΠΕΡΙΛΗΨΗ ΤΩΝ ΧΑΡΑΚΤΗΡΙΣΤΙΚΩΝ ΤΟΥ
ΠΡΟΪΟΝΤΟΣ
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
COENZILE 10,000µg/20ml, lyophilised, and solvent for solution for
injection for
cattle, horses, swine, dogs and cats.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_One bottle of lyophilisate contains:_
ACTIVE SUBSTANCE:
cobamamide.........................................10,000 µg
For a complete list of excipients, see section 6.1.
_One bottle of solvent contains:_
Water for injections.....................................20 ml
3.
PHARMACEUTICAL FORM
Lyophilisate and solvent for solution for injection.
4.
CLINICAL PARTICULARS
4.1.
TARGET SPECIES_ _
Cattle, horses, swine, dogs and cats.
4.2.
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In all states regarding retarded growth, insufficient or difficult
weight gain,
convalescence, hyporexia and anorexia. As stimulant in fatigue with
poor
performance
in
sporting
animals.
As
an
adjuvant
in
anaemia,
hepatopathies and neuropathies. As Vitamin B
12
in Vitamin B
12
avitaminosis and dysvitaminosis with a deficiency of this vitamin.
4.3.
CONTRAINDICATIONS
None.
4.4.
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5.
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
None.
4.6.
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None reported.
1/12
4.7.
USE DURING PREGNANCY, LACTATION OR LAY
COENZILE may be used during pregnancy and lactation.
4.8.
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9.
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Administer by the intramuscular route
CALVES, FOALS:
5-10ml (2,500 - 5,000µg) per day for 3-6 days.
PIGLETS:
2.5ml (1,250µg) per day, for 3 days.
ADULT CATTLE AND HORSES:10-20ml (5,000 - 10,000µg) per day, for 2-4
days.
ADULT SWINE:
5-10ml (2,500 - 5,000µg) per day, for 2-4 days.
DOGS AND CATS:
2.5-5ml (1,250 - 2,500µg